Scalable methods for producing recombinant adeno-associated viral (aav) vector in serum-free suspension cell culture system suitable for clinical use
AssigneeSpark Therapeutics, Inc.
InventorsGuang QU, Lin LU, John Fraser WRIGHT
Life of this patent
Estimating the term…
Abstract
Methods and compositions for transfecting cells with plasmids are disclosed. In certain embodiments, methods and compositions are disclosed in which transfection efficiency is significantly increased by contacting the cells being transduced with polyethyleneimine (PEI) that is free of nucleic acid during the transfection process. Therapeutically useful adeno-associated viral vectors generated according to the disclosed methods and compositions are also disclosed.
Claims69
A composition comprising a plasmid/PEI mixture, said plasmid/PEI mixture comprising components:
- (a) one or more plasmids comprising nucleic acids encoding AAV packaging proteins and/or nucleic acids encoding helper proteins;
- (b) a plasmid comprising a nucleic acid that encodes a protein or is transcribed into a transcript of interest;
- and
- (c) a polyethylenimine (PEI) solution,
- wherein said plasmids are in a molar ratio range of about 1:0.01 to about 1:100, or are in a molar ratio range of about 100:1 to about 1:0.01, and wherein the mixture of said components (a), (b) and (c) has optionally been incubated for a period of time from about 10 seconds to about 4 hours.
-8. (canceled)
-11. (canceled)
-19. (canceled)
A method for producing transfected cells, said method comprising:
- (a) providing a plasmid;
- (b) providing a solution comprising polyethylenimine (PEI);
- (c) mixing the plasmid of (a) with the PEI solution of (b), to produce a plasmid/PEI mixture, and optionally incubating said plasmid/PEI mixture for a period in the range of about 10 seconds to about 4 hours;
- (d) contacting cells with said plasmid/PEI mixture of step (c), to produce a plasmid/PEI cell culture;
- (e) adding Free PEI to said nucleic acid/PEI cell culture produced in step (d) to produce a Free PEI/plasmid/PEI cell culture;
- and
- (f) incubating said Free PEI/plasmid/PEI cell culture of step (e) for at least about 4 hours, thereby producing transfected cells.
A method for producing transfected cells that produce recombinant AAV vector comprising a nucleic acid that encodes a protein or is transcribed into a transcript of interest, said method comprising:
- (a) providing one or more plasmids comprising nucleic acids encoding AAV packaging proteins and/or nucleic acids encoding helper proteins;
- (b) providing a plasmid comprising a nucleic acid that encodes a protein or is transcribed into a transcript of interest;
- (c) providing a solution comprising polyethylenimine (PEI);
- (d) mixing the plasmids of steps (a) and (b) with the PEI solution of step (c), wherein said plasmids are in a molar ratio range of about 1:0.01 to about 1:100, or are in a molar ratio range of about 100:1 to about 1:0.01, to produce a plasmid/PEI mixture, and optionally incubating said plasmid/PEI mixture for a period in the range of about 10 seconds to about 4 hours;
- (e) contacting cells with said plasmid/PEI mixture of step (d), to produce a plasmid/PEI cell culture;
- (f) adding Free PEI to said plasmid/PEI cell culture produced in step (e) to produce a Free PEI/plasmid/PEI cell culture;
- and
- (g) incubating said Free PEI/plasmid/PEI cell culture of step (f) for at least about 4 hours, thereby producing transfected cells that produce recombinant AAV vector comprising a nucleic acid that encodes a protein or is transcribed into a transcript of interest.
A method for producing recombinant AAV vector comprising a nucleic acid that encodes a protein or is transcribed into a transcript of interest, said method comprising the steps:
- (a) providing one or more plasmids comprising nucleic acids encoding AAV packaging proteins and/or nucleic acids encoding helper proteins;
- (b) providing a plasmid comprising a nucleic acid that encodes a protein or is transcribed into a transcript of interest;
- (c) providing a solution comprising polyethylenimine (PEI);
- (d) mixing said plasmids of steps (a) and (b) with said PEI solution of step (c), wherein said plasmids are in a molar ratio range of about 1:0.01 to about 1:100, or are in a molar ratio range of about 100:1 to about 1:0.01, to produce a plasmid/PEI mixture, and optionally incubating the plasmid/PEI mixture for a period of time in the range of about 10 seconds to about 4 hours;
- (e) contacting cells with said plasmid/PEI mixture produced in step (d), to produce a plasmid/PEI cell culture;
- (f) adding Free PEI to said plasmid/PEI cell culture produced in step (e) to produce a Free PEI/plasmid/PEI cell culture;
- (g) incubating said plasmid/PEI cell culture of step (e) or said Free PEI/plasmid/PEI cell culture of step (f) for at least about 4 hours to produce transfected cells;
- (h) harvesting said transfected cells produced in step (g) and/or culture medium from the transfected cells produced in step (g) to produce a cell and/or culture medium harvest;
- and
- (i) isolating and/or purifying recombinant AAV vector from said cell and/or culture medium harvest produced in step (h) thereby producing recombinant AAV vector comprising a nucleic acid that encodes a protein or is transcribed into a transcript of interest.
A method for producing transfected cells that produce recombinant AAV vector comprising a nucleic acid that encodes a protein or is transcribed into a transcript of interest, said method comprising the steps:
- (a) providing a mixture of components (i), (ii) and (iii):
- (i) one or more plasmids comprising nucleic acids encoding AAV packaging proteins and/or nucleic acids encoding helper proteins;
- (ii) a plasmid comprising a nucleic acid that encodes a protein or is transcribed into a transcript of interest;
- and
- (iii) a polyethylenimine (PEI) solution,
- (b) mixing said plasmids (i) and (ii) with said PEI solution (iii) so that said plasmids are in a molar ratio range of about 1:0.01 to about 1:100, or in a molar ratio range of about 100:1 to about 1:0.01, to produce a plasmid/PEI mixture, and optionally incubating said plasmid/PEI mixture for a period of time in the range of about 10 seconds to about 4 hours;
- (c) contacting cells with said plasmid/PEI mixture produced in step (b) to produce a plasmid/PEI cell culture;
- (d) adding Free PEI to said plasmid/PEI cell culture produced in step (c) to produce a Free PEI/plasmid/PEI cell culture;
- (e) incubating said plasmid/PEI cell culture of step (c) or said Free PEI/plasmid/PEI cell culture of step (d) for at least about 4 hours to produce transfected cells that produce recombinant AAV vector comprising a nucleic acid that encodes a protein or is transcribed into a transcript of interest.
A method for producing recombinant AAV vector comprising a nucleic acid that encodes a protein or is transcribed into a transcript of interest, comprising the step:
- (a) providing a mixture of components (i), (ii) and (iii):
- (i) one or more plasmids comprising nucleic acids encoding AAV packaging proteins and/or nucleic acids encoding helper proteins;
- (ii) a plasmid comprising a nucleic acid that encodes a protein or is transcribed into a transcript of interest;
- and
- (iii) a polyethylenimine (PEI) solution,
- (b) mixing said plasmids (i) and (ii) with said PEI solution (iii) so that said plasmids are in a molar ratio range of about 1:0.01 to about 1:100, or are in a molar ratio range of about 100:1 to about 1:0.01, to produce a plasmid/PEI mixture, and optionally incubating said plasmid/PEI mixture for a period of time from about 10 seconds to about 4 hours;
- (c) contacting cells with said plasmid/PEI mixture produced in step (b) to produce a plasmid/PEI cell culture;
- (d) adding Free PEI to said plasmid/PEI cell culture produced in step (c) to produce a Free PEI/plasmid/PEI cell culture;
- (e) incubating said plasmid/PEI cell culture of step (c) or said Free PEI/plasmid/PEI cell culture of step (d) for at least about 4 hours to produce transfected cells;
- (f) harvesting said transfected cells produced in step (e) and/or culture medium from the transfected cells produced in step (e) to produce a cell and/or culture medium harvest;
- and
- (g) isolating and/or purifying recombinant AAV vector from the cell and/or culture medium harvest produced in step (f), thereby producing recombinant AAV vector comprising a nucleic acid that encodes a protein or is transcribed into a transcript of interest.
A method for producing recombinant AAV vector comprising a nucleic acid that encodes a protein or is transcribed into a transcript of interest, comprising the steps:
- (a) providing a mixture of components (i), (ii) and (iii):
- (i) one or more plasmids comprising nucleic acids encoding AAV packaging proteins and/or nucleic acids encoding helper proteins;
- (ii) a plasmid comprising a nucleic acid that encodes a protein or is transcribed into a transcript of interest;
- and
- (iii) a polyethylenimine (PEI) solution,
- wherein said plasmids (i) and (ii) are in a molar ratio range of about 1:0.01 to about 1:100, or are in a molar ratio range of about 100:1 to about 1:0.01, and wherein the mixture of components (i), (ii) and (iii) has optionally been incubated for a period of time from about 10 seconds to about 4 hours.
- (b) contacting cells with the mixture produced in step (a) to produce a plasmid/PEI cell culture;
- (c) adding Free PEI to said plasmid/PEI cell culture produced in step (b) to produce a Free PEI/plasmid/PEI cell culture;
- (d) incubating said plasmid/PEI cell culture of step (b) or said Free PEI/plasmid/PEI cell culture of step (c) for at least about 4 hours to produce transfected cells;
- (e) harvesting said transfected cells produced in step (d) and/or culture medium from the transfected cells produced in step (d) to produce a cell and/or culture medium harvest;
- and
- (f) isolating and/or purifying recombinant AAV vector from the cell and/or culture medium harvest produced in step (e), thereby producing recombinant AAV vector comprising a nucleic acid that encodes a protein or is transcribed into a transcript of interest.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
-43. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.